SOUTH DAKOTA DEPARTMENT OF HEALTH
FOR RELEASE: March 26, 2004
CONTACT: Lon Kightlinger, 605-773-3737

Nasal spray recalled due to contamination

     PIERRE ¯ The Centers for Disease Control and Prevention has notified the Department of Health of a voluntary recall of over-the counter oxymetazoline HCL 0.05%  nasal spray due to contamination with burkholderia cepacia complex bacteria. The spray is distributed as Major Twice-A-Day 12 Hour Nasal Spray.

     The manufacturer, Propharma Inc., has recalled lot# K4496 released 11/03 with an expiration date of 10/06. 

     Patients with underlying lung disease (especially cystic fibrosis) may be at increased risk for severe infections with B. cepacia complex. According to CDC, B. cepacia poses very little medical risk to healthy people; however, people whose health is otherwise compromised may be more susceptible.  If individuals have used this product and are concerned they should contact their healthcare provider.